| Literature DB >> 35651502 |
Abstract
The common feature of non-cross-linked hyaluronic acid nano-needles is that they penetrate the skin and dissolve rapidly, and the non-cross-linked hyaluronic acid will migrate under the skin, so it is difficult to maintain the long-term expansion effect in a fixed position. In order to achieve the relatively long-term antiwrinkle effect, a kind of cross-linked and non-cross-linked compound hyaluronic acid microne was prepared. By inserting the microne under the skin, dissolving the non-cross-linked part under the skin and introducing the cross-linked gel particles under the skin, the effect of extending the microne was achieved. The mechanical properties, permeability, and degradation rate of cross-linked and non-cross-linked hyaluronic acid composite nano-needles were studied in detail. Experimental results show that the higher the content of CHA, the slower the degradation rate of the microneedle, and the skin swelling of the HA_CHA (1 : 1) microneedle is the most lasting. With the increase of CHA content in microneedle matrix materials, the degree of epidermal expansion decreased. The preparation of cross-linked and non-cross-linked hyaluronic acid microneedles has the potential to be effectively used as dermal fillers in cosmetics or antiaging treatments.Entities:
Year: 2022 PMID: 35651502 PMCID: PMC9150987 DOI: 10.1155/2022/4565260
Source DB: PubMed Journal: Int J Anal Chem ISSN: 1687-8760 Impact factor: 1.698
Names and specifications of used pharmaceutical reagents.
| Drug name | Specifications |
|---|---|
| Sulfonyl rhodamine B | 75% |
| Sodium hyaluronate | MW = 447.37 nDA |
| Polydimethylsiloxane | 99.5% |
| Phosphate buffer | Sterile |
| Ehrlich | >99% |
| Heavy water | >99.9% |
| Sucrose | >99.0% |
| Vitamin C | 95% |
| Coenzyme Q10 | 95% |
| Vitamin A palmitate | 95% |
| Poly (PVC) | >79% |
| Polylactic acid | 50–60 kDA |
| Ethanol | 95% |
| Acetone | 99.5% |
| Isoflurane | 100 ML/bottle |
| 1,4-Butanediol glycidyl glycol | MW = 202.25 DA |
| Oil ether | |
| Potassium hydroxide | 2 MoL/L Aqueous solution |
| Glacial acetic acid | 99.5% |
| Sodium carbonate | >99.0% |
| Hyaluronidase | ≧300 units/Mg |
| Physiological saline | For mammals only |
| Trypan blue | 60% |
| Citric acid-sodium citrate is slow | 1 MoL/L, PH = 4.2− |
| Polylactic acid | 50–60 kDA |
Names and models of instruments used.
| The name of the instrument | Model |
|---|---|
| Ultrasonic cleaner | BXXW-30AL |
| Laser etching machine | VLs3.5, 50 W |
| Digital viscometer | nDJ-9s |
| The centrifuge | 5702RH |
| Vacuum drying oven | DZF-6050 |
| Vertical flow clean bench | sW-CJ-ZF |
| Enzyme standard instrument | FL |
| Handheld digital microscope | AD7013MZt |
| □CoRPoRAtion | |
| Fluorescence microscope | sZX7 |
| Ultrapure water machine | XYE-5-H |
| Dynamometer | MARk-10 |
| Inhalation anesthesia machine | VMR |
| Vacuum freeze dryer | VFD-1000 |
| Glucose monitor | Easy type |
Figure 1Chemical reaction equation for the preparation of CHA by BODE crosslinking agent.
Figure 2Axial mechanical strength of HA_CHA microneedles with different proportions.